Clinical trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Idiopathic Pulmonary Fibrosis, Open Label Extension
NCT00071461 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Idiopathic Pulmonary Fibrosis, Open Label Extension
- Lead sponsor
- Actelion
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 31, 2003
- Completion date
- May 31, 2010
- Enrollment
- 158 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.